<DOC>
	<DOCNO>NCT00940927</DOCNO>
	<brief_summary>The purpose study determine lung function response increase dos albuterol ( bronchodilator ) child adult asthma .</brief_summary>
	<brief_title>Dose-response Albuterol Asthmatics</brief_title>
	<detailed_description>Inhaled short-acting b2-agonists ( SABA ) potent bronchodilator use today treat acute symptom asthma albuterol , partial b2-agonist , frequently prescribe asthma medication US . Although universally use acute asthma symptom , SABA associate significant degree interpatient variability . Many study characterize SABA dose bronchodilator response relationship control condition . However , study explore magnitude source bronchodilator response variability , study characterize dose versus bronchodilator response relationship use population pharmacokinetic/pharmacodynamic ( PPK/PD ) modeling . In present study , characterize relationship inhaled dos albuterol bronchodilation 81 child adult moderate severe persistent asthma use population pharmacodynamic approach . The purpose study obtain estimate pharmacodynamic parameter characterize dose-response curve , include maximal dose bronchodilation , quantify identify source interpatient pharmacodynamic variability .</detailed_description>
	<mesh_term>Albuterol</mesh_term>
	<criteria>Eligibility Criteria : Welldefined history physician diagnose asthma Any ethnic background 8 65 year old Baseline prebronchodilator FEV1 40 % 80 % predicted age , height , gender No oral corticosteroid use , emergency room visit , hospitalization within previous 3 month Nonsmokers less 5 packyear history smoke previous year Normal physical exam confounding disease select Able withhold inhale shortacting b2agonists inhale anticholinergic drug 8 hour , oral antihistamine 5 day , theophylline 24 hour , cromolyn , nedocromil , inhale corticosteroid 2 hour prior study .</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Albuterol</keyword>
	<keyword>Forced expiratory volume one second</keyword>
	<keyword>Dose fifty percent maximum effect</keyword>
	<keyword>Maximum effective dose</keyword>
	<keyword>Metered dose inhaler</keyword>
	<keyword>Nebulizer</keyword>
</DOC>